Company / R&D Expense
Bruker R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$395.2M
FY2025
5-year range
$220.8M / $395.2M
FY2021-FY2025
Trend
+5.0%
vs FY2024
Sector context
#18 of 105
Health Care
What the data says
Bruker's r&d expense of $395M is higher than 83% of companies in the Health Care sector (FY2025). R&D Expense has increased for 9 consecutive years, from $148M in FY2016 to $395M in FY2025.
Based on SEC 10-K filings.
$395M in FY2025 with a 5-year CAGR of +14.8%. Top quartile in the Health Care sector.
Improved from $295M to $395M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +18.8%
- 5-Year CAGR
- +14.8%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 105This company $395.2M Sector average $284.2M
▼
+39.1% above sector average
Key checks
Key Insights
- Bruker's r&d expense has grown for 9 consecutive years.
- 5-year CAGR of +14.8%, indicating consistent growth.
- In FY2025, r&d expense increased 5.0% year-over-year.
- Ranks #18 out of 105 companies in the Health Care sector.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $395.2M | +5.0% |
| FY2024 | $376.5M | +27.7% |
| FY2023 | $294.8M | +25.0% |
| FY2022 | $235.9M | +6.8% |
| FY2021 | $220.8M | +11.5% |
| FY2020 | $198.0M | +5.5% |
| FY2019 | $187.7M | +8.2% |
| FY2018 | $173.4M | +7.3% |
| FY2017 | $161.6M | +9.3% |
| FY2016 | $147.9M | +1.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026